Intec Pharma is a development stage, publicly-traded (TASE: INTP) biopharmaceutical company based in Jerusalem, Israel. Intec Pharma is applying its innovative proprietary gastric retention technology, the Accordion Pill™, to develop improved formulations of drugs.

The Accordion Pill™, a novel gastro-retentive delivery system, significantly improves the Pharmacokinetics and pharmacodynamics of various drugs.

The Accordion Pill™ is an effective delivery solution for drugs that are characterized by one of the following:
• Narrow Absorption Window (poor colonic absorption).
• Poor solubility, BCS class II or IV.
• Act locally, in the stomach or in the upper part of the GI tract.
• Adverse effects correlate with the drug reaching the distal parts of the GI tract.